Ruqin Gao
- Infectious Diseases top 0.5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Neurology top 2%
- Topics
- SARS-CoV-2 and COVID-19 Research (4 papers)COVID-19 epidemiological studies (3 papers)COVID-19 Clinical Research Studies (3 papers)
- Journals
- JAMANature CommunicationsPLoS ONE
- Partner nations
- ChinaUnited KingdomHong Kong
In The Last Decade
Ruqin Gao
14 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Infectious Diseases 2.5k
- Radiology, Nuclear Medicine and Imaging 815
- Oncology 632
- Pulmonary and Respiratory Medicine 558
- Neurology 525
Countries citing papers authored by Ruqin Gao
This map shows the geographic impact of Ruqin Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruqin Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruqin Gao more than expected).
Fields of papers citing papers by Ruqin Gao
This network shows the impact of papers produced by Ruqin Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruqin Gao. The network helps show where Ruqin Gao may publish in the future.
Co-authorship network of co-authors of Ruqin Gao
This figure shows the co-authorship network connecting the top 25 collaborators of Ruqin Gao. A scholar is included among the top collaborators of Ruqin Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruqin Gao. Ruqin Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 5 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 164 | |
| 8 | 52 | |
| 9 | 100 | |
| 10 | 27 | |
| 11 | 21 | |
| 12 | Detection of SARS-CoV-2 in Different Types of Clinical Specimensbreakdown → | 3448 |
| 13 | 45 | |
| 14 | 38 | |
| 15 | 17 |
About Ruqin Gao
Ruqin Gao is a scholar working on Modeling and Simulation, Infectious Diseases and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 3.9k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 epidemiological studies (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Infectious Diseases (2.5k citations), General Dentistry (116 citations) and Modeling and Simulation (232 citations). Ruqin Gao has collaborated with scholars based in China, United Kingdom and Hong Kong. Frequent co-authors include Guizhen Wu, Wenjie Tan, Yanli Xu, Kai Han, Wen‐Ching Wang, Roujian Lu, Fachun Jiang, Wei Ni, Xiaowen Hu and Yuhan Xing. Their work appears in journals such as JAMA, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.